nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1B1—breast cancer	0.196	0.605	CbGaD
Lovastatin—CYP2D6—breast cancer	0.0497	0.154	CbGaD
Lovastatin—CYP3A4—breast cancer	0.0426	0.132	CbGaD
Lovastatin—ABCB1—breast cancer	0.0355	0.11	CbGaD
Lovastatin—SLCO1A2—Chlorambucil—breast cancer	0.0293	0.072	CbGbCtD
Lovastatin—UGT2B7—Epirubicin—breast cancer	0.0161	0.0395	CbGbCtD
Lovastatin—UGT1A1—Irinotecan—breast cancer	0.0135	0.0332	CbGbCtD
Lovastatin—CYP2C9—Anastrozole—breast cancer	0.0108	0.0264	CbGbCtD
Lovastatin—CYP3A5—Lapatinib—breast cancer	0.0107	0.0263	CbGbCtD
Lovastatin—ABCC2—Tamoxifen—breast cancer	0.0107	0.0263	CbGbCtD
Lovastatin—CYP2C8—Lapatinib—breast cancer	0.0103	0.0253	CbGbCtD
Lovastatin—ABCB1—Toremifene—breast cancer	0.00957	0.0235	CbGbCtD
Lovastatin—SLCO1B1—Irinotecan—breast cancer	0.00937	0.023	CbGbCtD
Lovastatin—CYP2C19—Lapatinib—breast cancer	0.00865	0.0212	CbGbCtD
Lovastatin—ABCC2—Paclitaxel—breast cancer	0.00834	0.0205	CbGbCtD
Lovastatin—CYP3A4—Exemestane—breast cancer	0.00827	0.0203	CbGbCtD
Lovastatin—ABCC2—Irinotecan—breast cancer	0.00823	0.0202	CbGbCtD
Lovastatin—CYP2C9—Idarubicin—breast cancer	0.00817	0.02	CbGbCtD
Lovastatin—ABCC2—Carboplatin—breast cancer	0.00785	0.0193	CbGbCtD
Lovastatin—CYP2C8—Raloxifene—breast cancer	0.00781	0.0192	CbGbCtD
Lovastatin—CYP2D6—Idarubicin—breast cancer	0.00747	0.0183	CbGbCtD
Lovastatin—ABCC2—Vinblastine—breast cancer	0.00732	0.018	CbGbCtD
Lovastatin—CYP3A7—Tamoxifen—breast cancer	0.00716	0.0176	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00716	0.0176	CbGbCtD
Lovastatin—CYP3A4—Letrozole—breast cancer	0.00703	0.0173	CbGbCtD
Lovastatin—ABCB1—Lapatinib—breast cancer	0.00698	0.0171	CbGbCtD
Lovastatin—CYP3A4—Anastrozole—breast cancer	0.00627	0.0154	CbGbCtD
Lovastatin—ABCC2—Docetaxel—breast cancer	0.00603	0.0148	CbGbCtD
Lovastatin—CYP3A4—Toremifene—breast cancer	0.00573	0.0141	CbGbCtD
Lovastatin—CYP3A7—Paclitaxel—breast cancer	0.00557	0.0137	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00557	0.0137	CbGbCtD
Lovastatin—CYP3A7—Irinotecan—breast cancer	0.0055	0.0135	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0055	0.0135	CbGbCtD
Lovastatin—CYP3A5—Tamoxifen—breast cancer	0.00537	0.0132	CbGbCtD
Lovastatin—CYP3A4—Fulvestrant—breast cancer	0.00533	0.0131	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—breast cancer	0.00525	0.0129	CbGbCtD
Lovastatin—CYP2C8—Tamoxifen—breast cancer	0.00516	0.0127	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—breast cancer	0.00496	0.0122	CbGbCtD
Lovastatin—CYP3A4—Thiotepa—breast cancer	0.00475	0.0117	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—breast cancer	0.0045	0.011	CbGbCtD
Lovastatin—CYP2C9—Capecitabine—breast cancer	0.00448	0.011	CbGbCtD
Lovastatin—ABCC2—Methotrexate—breast cancer	0.00436	0.0107	CbGbCtD
Lovastatin—CYP3A4—Ixabepilone—breast cancer	0.00434	0.0107	CbGbCtD
Lovastatin—CYP2C19—Tamoxifen—breast cancer	0.00433	0.0106	CbGbCtD
Lovastatin—CYP3A4—Lapatinib—breast cancer	0.00418	0.0103	CbGbCtD
Lovastatin—CYP3A5—Paclitaxel—breast cancer	0.00418	0.0103	CbGbCtD
Lovastatin—CYP3A5—Irinotecan—breast cancer	0.00412	0.0101	CbGbCtD
Lovastatin—CYP3A7—Docetaxel—breast cancer	0.00403	0.00988	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00403	0.00988	CbGbCtD
Lovastatin—CYP2C8—Paclitaxel—breast cancer	0.00402	0.00986	CbGbCtD
Lovastatin—ABCB1—Vinorelbine—breast cancer	0.00387	0.0095	CbGbCtD
Lovastatin—CYP2C8—Fluorouracil—breast cancer	0.0038	0.00933	CbGbCtD
Lovastatin—CYP2D6—Vinorelbine—breast cancer	0.00365	0.00895	CbGbCtD
Lovastatin—CYP2C9—Tamoxifen—breast cancer	0.0036	0.00883	CbGbCtD
Lovastatin—ABCB1—Tamoxifen—breast cancer	0.00349	0.00857	CbGbCtD
Lovastatin—ABCB1—Mitoxantrone—breast cancer	0.00341	0.00836	CbGbCtD
Lovastatin—CYP2D6—Tamoxifen—breast cancer	0.00329	0.00808	CbGbCtD
Lovastatin—CYP3A4—Raloxifene—breast cancer	0.00317	0.00777	CbGbCtD
Lovastatin—CYP3A5—Docetaxel—breast cancer	0.00302	0.00741	CbGbCtD
Lovastatin—ABCB1—Gemcitabine—breast cancer	0.00301	0.00739	CbGbCtD
Lovastatin—CYP2C9—Paclitaxel—breast cancer	0.0028	0.00688	CbGbCtD
Lovastatin—ABCB1—Paclitaxel—breast cancer	0.00272	0.00667	CbGbCtD
Lovastatin—ABCB1—Irinotecan—breast cancer	0.00268	0.00658	CbGbCtD
Lovastatin—CYP2C9—Fluorouracil—breast cancer	0.00265	0.00651	CbGbCtD
Lovastatin—ITGAL—mammary gland—breast cancer	0.00246	0.0599	CbGeAlD
Lovastatin—ABCB1—Vinblastine—breast cancer	0.00239	0.00585	CbGbCtD
Lovastatin—CYP3A4—Vinorelbine—breast cancer	0.00232	0.00569	CbGbCtD
Lovastatin—CYP2D6—Vinblastine—breast cancer	0.00225	0.00551	CbGbCtD
Lovastatin—CYP3A4—Tamoxifen—breast cancer	0.00209	0.00514	CbGbCtD
Lovastatin—CYP3A4—Mitoxantrone—breast cancer	0.00204	0.00501	CbGbCtD
Lovastatin—ITGAL—nipple—breast cancer	0.00203	0.0495	CbGeAlD
Lovastatin—PON3—nipple—breast cancer	0.00199	0.0486	CbGeAlD
Lovastatin—ABCB1—Docetaxel—breast cancer	0.00197	0.00482	CbGbCtD
Lovastatin—CYP3A4—Paclitaxel—breast cancer	0.00163	0.004	CbGbCtD
Lovastatin—CYP3A4—Irinotecan—breast cancer	0.00161	0.00394	CbGbCtD
Lovastatin—ABCB1—Doxorubicin—breast cancer	0.00147	0.0036	CbGbCtD
Lovastatin—CYP3A4—Vinblastine—breast cancer	0.00143	0.00351	CbGbCtD
Lovastatin—ABCB1—Methotrexate—breast cancer	0.00142	0.00348	CbGbCtD
Lovastatin—CYP2D6—Doxorubicin—breast cancer	0.00138	0.00339	CbGbCtD
Lovastatin—ITGAL—epithelium—breast cancer	0.00137	0.0333	CbGeAlD
Lovastatin—ITGAL—endometrium—breast cancer	0.00123	0.0299	CbGeAlD
Lovastatin—CYP3A4—Docetaxel—breast cancer	0.00118	0.00289	CbGbCtD
Lovastatin—ITGAL—adipose tissue—breast cancer	0.00111	0.0269	CbGeAlD
Lovastatin—HDAC2—Gefitinib—Lapatinib—breast cancer	0.0011	0.58	CbGdCrCtD
Lovastatin—PON3—pituitary gland—breast cancer	0.00109	0.0265	CbGeAlD
Lovastatin—PON3—adipose tissue—breast cancer	0.00109	0.0264	CbGeAlD
Lovastatin—ITGAL—adrenal gland—breast cancer	0.000993	0.0242	CbGeAlD
Lovastatin—HDAC2—mammary gland—breast cancer	0.000983	0.0239	CbGeAlD
Lovastatin—ITGAL—bone marrow—breast cancer	0.00096	0.0234	CbGeAlD
Lovastatin—PON3—bone marrow—breast cancer	0.000942	0.0229	CbGeAlD
Lovastatin—ITGAL—female gonad—breast cancer	0.000926	0.0225	CbGeAlD
Lovastatin—PON3—female gonad—breast cancer	0.000908	0.0221	CbGeAlD
Lovastatin—Simvastatin—SLCO1B1—breast cancer	0.000885	0.271	CrCbGaD
Lovastatin—CYP3A4—Doxorubicin—breast cancer	0.000878	0.00215	CbGbCtD
Lovastatin—Pravastatin—SLCO1B1—breast cancer	0.000867	0.265	CrCbGaD
Lovastatin—ITGAL—endocrine gland—breast cancer	0.000861	0.021	CbGeAlD
Lovastatin—SLCO1B1—mammary gland—breast cancer	0.00085	0.0207	CbGeAlD
Lovastatin—PON3—endocrine gland—breast cancer	0.000844	0.0206	CbGeAlD
Lovastatin—HDAC2—Topotecan—Irinotecan—breast cancer	0.000799	0.42	CbGdCrCtD
Lovastatin—HMGCR—nipple—breast cancer	0.000734	0.0179	CbGeAlD
Lovastatin—UGT1A3—endocrine gland—breast cancer	0.000732	0.0178	CbGeAlD
Lovastatin—HDAC2—embryo—breast cancer	0.000671	0.0163	CbGeAlD
Lovastatin—ITGAL—lymph node—breast cancer	0.000595	0.0145	CbGeAlD
Lovastatin—HDAC2—epithelium—breast cancer	0.000547	0.0133	CbGeAlD
Lovastatin—HDAC2—skin of body—breast cancer	0.000521	0.0127	CbGeAlD
Lovastatin—UGT2B7—female reproductive system—breast cancer	0.000497	0.0121	CbGeAlD
Lovastatin—HMGCR—epithelium—breast cancer	0.000494	0.012	CbGeAlD
Lovastatin—HDAC2—endometrium—breast cancer	0.000491	0.012	CbGeAlD
Lovastatin—CYP2C8—mammary gland—breast cancer	0.000483	0.0118	CbGeAlD
Lovastatin—HMGCR—skin of body—breast cancer	0.00047	0.0114	CbGeAlD
Lovastatin—HDAC2—uterus—breast cancer	0.000452	0.011	CbGeAlD
Lovastatin—HDAC2—pituitary gland—breast cancer	0.000444	0.0108	CbGeAlD
Lovastatin—HMGCR—endometrium—breast cancer	0.000443	0.0108	CbGeAlD
Lovastatin—HDAC2—adipose tissue—breast cancer	0.000442	0.0108	CbGeAlD
Lovastatin—CYP3A7—endocrine gland—breast cancer	0.000434	0.0106	CbGeAlD
Lovastatin—CYP2C9—mammary gland—breast cancer	0.000429	0.0104	CbGeAlD
Lovastatin—UGT2B7—endocrine gland—breast cancer	0.00042	0.0102	CbGeAlD
Lovastatin—HMGCR—uterus—breast cancer	0.000408	0.00994	CbGeAlD
Lovastatin—HDAC2—female reproductive system—breast cancer	0.000407	0.0099	CbGeAlD
Lovastatin—HMGCR—pituitary gland—breast cancer	0.000401	0.00976	CbGeAlD
Lovastatin—HMGCR—adipose tissue—breast cancer	0.000399	0.00972	CbGeAlD
Lovastatin—HDAC2—adrenal gland—breast cancer	0.000397	0.00966	CbGeAlD
Lovastatin—HDAC2—bone marrow—breast cancer	0.000384	0.00935	CbGeAlD
Lovastatin—Pravastatin—ABCG2—breast cancer	0.000377	0.115	CrCbGaD
Lovastatin—HDAC2—female gonad—breast cancer	0.00037	0.00901	CbGeAlD
Lovastatin—HMGCR—female reproductive system—breast cancer	0.000367	0.00893	CbGeAlD
Lovastatin—HMGCR—adrenal gland—breast cancer	0.000358	0.00872	CbGeAlD
Lovastatin—UGT1A1—endocrine gland—breast cancer	0.000357	0.0087	CbGeAlD
Lovastatin—SLCO1B1—female reproductive system—breast cancer	0.000351	0.00856	CbGeAlD
Lovastatin—HMGCR—bone marrow—breast cancer	0.000346	0.00843	CbGeAlD
Lovastatin—HDAC2—endocrine gland—breast cancer	0.000344	0.00838	CbGeAlD
Lovastatin—HMGCR—female gonad—breast cancer	0.000334	0.00813	CbGeAlD
Lovastatin—HMGCR—endocrine gland—breast cancer	0.00031	0.00756	CbGeAlD
Lovastatin—SLCO1B1—endocrine gland—breast cancer	0.000297	0.00724	CbGeAlD
Lovastatin—ABCC2—female reproductive system—breast cancer	0.000266	0.00649	CbGeAlD
Lovastatin—ABCC2—adrenal gland—breast cancer	0.00026	0.00633	CbGeAlD
Lovastatin—SLCO1A2—endocrine gland—breast cancer	0.000242	0.00589	CbGeAlD
Lovastatin—CYP2C8—endometrium—breast cancer	0.000241	0.00587	CbGeAlD
Lovastatin—HDAC2—lymph node—breast cancer	0.000238	0.00579	CbGeAlD
Lovastatin—ABCC2—endocrine gland—breast cancer	0.000225	0.00549	CbGeAlD
Lovastatin—Simvastatin—CYP2D6—breast cancer	0.000225	0.0687	CrCbGaD
Lovastatin—Pravastatin—CYP2D6—breast cancer	0.00022	0.0672	CrCbGaD
Lovastatin—CYP2C8—pituitary gland—breast cancer	0.000218	0.00532	CbGeAlD
Lovastatin—HMGCR—lymph node—breast cancer	0.000215	0.00523	CbGeAlD
Lovastatin—CYP2C8—female reproductive system—breast cancer	0.0002	0.00487	CbGeAlD
Lovastatin—CYP3A5—adipose tissue—breast cancer	0.000196	0.00478	CbGeAlD
Lovastatin—CYP2C19—endocrine gland—breast cancer	0.000194	0.00472	CbGeAlD
Lovastatin—Simvastatin—CYP3A4—breast cancer	0.000193	0.0589	CrCbGaD
Lovastatin—Pravastatin—CYP3A4—breast cancer	0.000189	0.0576	CrCbGaD
Lovastatin—CYP2C9—female reproductive system—breast cancer	0.000178	0.00432	CbGeAlD
Lovastatin—CYP2C8—endocrine gland—breast cancer	0.000169	0.00412	CbGeAlD
Lovastatin—CYP3A5—female gonad—breast cancer	0.000164	0.004	CbGeAlD
Lovastatin—Simvastatin—ABCB1—breast cancer	0.00016	0.049	CrCbGaD
Lovastatin—ABCB1—embryo—breast cancer	0.000158	0.00385	CbGeAlD
Lovastatin—Pravastatin—ABCB1—breast cancer	0.000157	0.048	CrCbGaD
Lovastatin—ABCC2—lymph node—breast cancer	0.000156	0.0038	CbGeAlD
Lovastatin—CYP3A5—endocrine gland—breast cancer	0.000153	0.00372	CbGeAlD
Lovastatin—CYP2C9—endocrine gland—breast cancer	0.00015	0.00366	CbGeAlD
Lovastatin—CYP3A4—female reproductive system—breast cancer	0.000135	0.0033	CbGeAlD
Lovastatin—CYP2D6—female reproductive system—breast cancer	0.000133	0.00324	CbGeAlD
Lovastatin—ABCB1—epithelium—breast cancer	0.000129	0.00314	CbGeAlD
Lovastatin—CYP2D6—female gonad—breast cancer	0.000121	0.00295	CbGeAlD
Lovastatin—ABCB1—endometrium—breast cancer	0.000116	0.00282	CbGeAlD
Lovastatin—CYP3A4—endocrine gland—breast cancer	0.000115	0.00279	CbGeAlD
Lovastatin—CYP2D6—endocrine gland—breast cancer	0.000113	0.00274	CbGeAlD
Lovastatin—ABCB1—uterus—breast cancer	0.000107	0.0026	CbGeAlD
Lovastatin—ABCB1—pituitary gland—breast cancer	0.000105	0.00255	CbGeAlD
Lovastatin—ABCB1—adipose tissue—breast cancer	0.000104	0.00254	CbGeAlD
Lovastatin—ABCB1—female reproductive system—breast cancer	9.58e-05	0.00233	CbGeAlD
Lovastatin—ABCB1—adrenal gland—breast cancer	9.35e-05	0.00228	CbGeAlD
Lovastatin—ABCB1—bone marrow—breast cancer	9.05e-05	0.0022	CbGeAlD
Lovastatin—ABCB1—female gonad—breast cancer	8.72e-05	0.00212	CbGeAlD
Lovastatin—ABCB1—endocrine gland—breast cancer	8.11e-05	0.00197	CbGeAlD
Lovastatin—ABCB1—lymph node—breast cancer	5.61e-05	0.00136	CbGeAlD
Lovastatin—Constipation—Paclitaxel—breast cancer	4.15e-05	0.000346	CcSEcCtD
Lovastatin—Confusional state—Docetaxel—breast cancer	4.15e-05	0.000346	CcSEcCtD
Lovastatin—Anxiety—Capecitabine—breast cancer	4.14e-05	0.000345	CcSEcCtD
Lovastatin—Photosensitivity reaction—Doxorubicin—breast cancer	4.12e-05	0.000343	CcSEcCtD
Lovastatin—Anaphylactic shock—Docetaxel—breast cancer	4.11e-05	0.000343	CcSEcCtD
Lovastatin—Discomfort—Capecitabine—breast cancer	4.1e-05	0.000342	CcSEcCtD
Lovastatin—Pruritus—Gemcitabine—breast cancer	4.1e-05	0.000342	CcSEcCtD
Lovastatin—Nausea—Thiotepa—breast cancer	4.09e-05	0.000341	CcSEcCtD
Lovastatin—Infection—Docetaxel—breast cancer	4.09e-05	0.000341	CcSEcCtD
Lovastatin—Sinusitis—Epirubicin—breast cancer	4.08e-05	0.00034	CcSEcCtD
Lovastatin—Diarrhoea—Mitoxantrone—breast cancer	4.07e-05	0.000339	CcSEcCtD
Lovastatin—Diarrhoea—Irinotecan—breast cancer	4.07e-05	0.000339	CcSEcCtD
Lovastatin—Dry mouth—Capecitabine—breast cancer	4.06e-05	0.000339	CcSEcCtD
Lovastatin—Pruritus—Fluorouracil—breast cancer	4.03e-05	0.000336	CcSEcCtD
Lovastatin—Thrombocytopenia—Docetaxel—breast cancer	4.03e-05	0.000336	CcSEcCtD
Lovastatin—Confusional state—Capecitabine—breast cancer	4.01e-05	0.000335	CcSEcCtD
Lovastatin—Feeling abnormal—Paclitaxel—breast cancer	4e-05	0.000333	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	3.99e-05	0.000333	CcSEcCtD
Lovastatin—Gastrointestinal pain—Paclitaxel—breast cancer	3.97e-05	0.000331	CcSEcCtD
Lovastatin—Diarrhoea—Gemcitabine—breast cancer	3.96e-05	0.000331	CcSEcCtD
Lovastatin—Infection—Capecitabine—breast cancer	3.96e-05	0.00033	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—breast cancer	3.94e-05	0.000329	CcSEcCtD
Lovastatin—Neuropathy peripheral—Doxorubicin—breast cancer	3.94e-05	0.000329	CcSEcCtD
Lovastatin—Dizziness—Irinotecan—breast cancer	3.93e-05	0.000328	CcSEcCtD
Lovastatin—Anorexia—Docetaxel—breast cancer	3.92e-05	0.000327	CcSEcCtD
Lovastatin—Urinary tract infection—Doxorubicin—breast cancer	3.91e-05	0.000326	CcSEcCtD
Lovastatin—Hepatitis—Epirubicin—breast cancer	3.9e-05	0.000325	CcSEcCtD
Lovastatin—Diarrhoea—Fluorouracil—breast cancer	3.9e-05	0.000325	CcSEcCtD
Lovastatin—Thrombocytopenia—Capecitabine—breast cancer	3.9e-05	0.000325	CcSEcCtD
Lovastatin—Urticaria—Paclitaxel—breast cancer	3.85e-05	0.000321	CcSEcCtD
Lovastatin—Body temperature increased—Paclitaxel—breast cancer	3.84e-05	0.00032	CcSEcCtD
Lovastatin—Abdominal pain—Paclitaxel—breast cancer	3.84e-05	0.00032	CcSEcCtD
Lovastatin—Anorexia—Capecitabine—breast cancer	3.8e-05	0.000316	CcSEcCtD
Lovastatin—Vomiting—Mitoxantrone—breast cancer	3.78e-05	0.000315	CcSEcCtD
Lovastatin—Vomiting—Irinotecan—breast cancer	3.78e-05	0.000315	CcSEcCtD
Lovastatin—Sinusitis—Doxorubicin—breast cancer	3.78e-05	0.000315	CcSEcCtD
Lovastatin—Dizziness—Fluorouracil—breast cancer	3.77e-05	0.000314	CcSEcCtD
Lovastatin—Rash—Mitoxantrone—breast cancer	3.75e-05	0.000313	CcSEcCtD
Lovastatin—Rash—Irinotecan—breast cancer	3.75e-05	0.000313	CcSEcCtD
Lovastatin—Dermatitis—Irinotecan—breast cancer	3.75e-05	0.000312	CcSEcCtD
Lovastatin—Dermatitis—Mitoxantrone—breast cancer	3.75e-05	0.000312	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Docetaxel—breast cancer	3.75e-05	0.000312	CcSEcCtD
Lovastatin—Chills—Methotrexate—breast cancer	3.74e-05	0.000312	CcSEcCtD
Lovastatin—Headache—Mitoxantrone—breast cancer	3.73e-05	0.000311	CcSEcCtD
Lovastatin—Headache—Irinotecan—breast cancer	3.73e-05	0.000311	CcSEcCtD
Lovastatin—Insomnia—Docetaxel—breast cancer	3.72e-05	0.00031	CcSEcCtD
Lovastatin—Paraesthesia—Docetaxel—breast cancer	3.69e-05	0.000308	CcSEcCtD
Lovastatin—Erythema multiforme—Epirubicin—breast cancer	3.69e-05	0.000308	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—breast cancer	3.69e-05	0.000307	CcSEcCtD
Lovastatin—Vomiting—Gemcitabine—breast cancer	3.68e-05	0.000307	CcSEcCtD
Lovastatin—Dyspnoea—Docetaxel—breast cancer	3.67e-05	0.000306	CcSEcCtD
Lovastatin—Rash—Gemcitabine—breast cancer	3.65e-05	0.000305	CcSEcCtD
Lovastatin—Dermatitis—Gemcitabine—breast cancer	3.65e-05	0.000304	CcSEcCtD
Lovastatin—Headache—Gemcitabine—breast cancer	3.63e-05	0.000303	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Capecitabine—breast cancer	3.63e-05	0.000302	CcSEcCtD
Lovastatin—Flushing—Epirubicin—breast cancer	3.62e-05	0.000302	CcSEcCtD
Lovastatin—Vomiting—Fluorouracil—breast cancer	3.62e-05	0.000302	CcSEcCtD
Lovastatin—Dyspepsia—Docetaxel—breast cancer	3.62e-05	0.000302	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—breast cancer	3.61e-05	0.000301	CcSEcCtD
Lovastatin—Insomnia—Capecitabine—breast cancer	3.6e-05	0.0003	CcSEcCtD
Lovastatin—Rash—Fluorouracil—breast cancer	3.59e-05	0.000299	CcSEcCtD
Lovastatin—Dermatitis—Fluorouracil—breast cancer	3.59e-05	0.000299	CcSEcCtD
Lovastatin—Paraesthesia—Capecitabine—breast cancer	3.58e-05	0.000298	CcSEcCtD
Lovastatin—Decreased appetite—Docetaxel—breast cancer	3.57e-05	0.000298	CcSEcCtD
Lovastatin—Hypersensitivity—Paclitaxel—breast cancer	3.57e-05	0.000298	CcSEcCtD
Lovastatin—Headache—Fluorouracil—breast cancer	3.57e-05	0.000298	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—breast cancer	3.56e-05	0.000296	CcSEcCtD
Lovastatin—Dyspnoea—Capecitabine—breast cancer	3.55e-05	0.000296	CcSEcCtD
Lovastatin—Fatigue—Docetaxel—breast cancer	3.55e-05	0.000296	CcSEcCtD
Lovastatin—Nausea—Mitoxantrone—breast cancer	3.53e-05	0.000295	CcSEcCtD
Lovastatin—Nausea—Irinotecan—breast cancer	3.53e-05	0.000295	CcSEcCtD
Lovastatin—Constipation—Docetaxel—breast cancer	3.52e-05	0.000293	CcSEcCtD
Lovastatin—Pain—Docetaxel—breast cancer	3.52e-05	0.000293	CcSEcCtD
Lovastatin—Back pain—Methotrexate—breast cancer	3.51e-05	0.000293	CcSEcCtD
Lovastatin—Dyspepsia—Capecitabine—breast cancer	3.5e-05	0.000292	CcSEcCtD
Lovastatin—Chills—Epirubicin—breast cancer	3.5e-05	0.000292	CcSEcCtD
Lovastatin—Asthenia—Paclitaxel—breast cancer	3.48e-05	0.00029	CcSEcCtD
Lovastatin—Decreased appetite—Capecitabine—breast cancer	3.46e-05	0.000289	CcSEcCtD
Lovastatin—Alopecia—Epirubicin—breast cancer	3.45e-05	0.000288	CcSEcCtD
Lovastatin—Nausea—Gemcitabine—breast cancer	3.44e-05	0.000287	CcSEcCtD
Lovastatin—Fatigue—Capecitabine—breast cancer	3.43e-05	0.000286	CcSEcCtD
Lovastatin—Pruritus—Paclitaxel—breast cancer	3.43e-05	0.000286	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—breast cancer	3.42e-05	0.000285	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—breast cancer	3.42e-05	0.000285	CcSEcCtD
Lovastatin—Constipation—Capecitabine—breast cancer	3.4e-05	0.000284	CcSEcCtD
Lovastatin—Pain—Capecitabine—breast cancer	3.4e-05	0.000284	CcSEcCtD
Lovastatin—Feeling abnormal—Docetaxel—breast cancer	3.39e-05	0.000283	CcSEcCtD
Lovastatin—Nausea—Fluorouracil—breast cancer	3.38e-05	0.000282	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—breast cancer	3.37e-05	0.000281	CcSEcCtD
Lovastatin—Gastrointestinal pain—Docetaxel—breast cancer	3.36e-05	0.00028	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—breast cancer	3.35e-05	0.00028	CcSEcCtD
Lovastatin—Flatulence—Epirubicin—breast cancer	3.35e-05	0.000279	CcSEcCtD
Lovastatin—Dysgeusia—Epirubicin—breast cancer	3.33e-05	0.000277	CcSEcCtD
Lovastatin—Diarrhoea—Paclitaxel—breast cancer	3.32e-05	0.000277	CcSEcCtD
Lovastatin—Back pain—Epirubicin—breast cancer	3.29e-05	0.000274	CcSEcCtD
Lovastatin—Feeling abnormal—Capecitabine—breast cancer	3.28e-05	0.000274	CcSEcCtD
Lovastatin—Malaise—Methotrexate—breast cancer	3.28e-05	0.000273	CcSEcCtD
Lovastatin—Muscle spasms—Epirubicin—breast cancer	3.27e-05	0.000272	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—breast cancer	3.26e-05	0.000272	CcSEcCtD
Lovastatin—Gastrointestinal pain—Capecitabine—breast cancer	3.26e-05	0.000271	CcSEcCtD
Lovastatin—Abdominal pain—Docetaxel—breast cancer	3.25e-05	0.000271	CcSEcCtD
Lovastatin—Body temperature increased—Docetaxel—breast cancer	3.25e-05	0.000271	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—breast cancer	3.25e-05	0.000271	CcSEcCtD
Lovastatin—Chills—Doxorubicin—breast cancer	3.24e-05	0.00027	CcSEcCtD
Lovastatin—Dizziness—Paclitaxel—breast cancer	3.21e-05	0.000267	CcSEcCtD
Lovastatin—Vision blurred—Epirubicin—breast cancer	3.2e-05	0.000267	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—breast cancer	3.19e-05	0.000266	CcSEcCtD
Lovastatin—Urticaria—Capecitabine—breast cancer	3.16e-05	0.000264	CcSEcCtD
Lovastatin—Ill-defined disorder—Epirubicin—breast cancer	3.15e-05	0.000263	CcSEcCtD
Lovastatin—Abdominal pain—Capecitabine—breast cancer	3.15e-05	0.000262	CcSEcCtD
Lovastatin—Body temperature increased—Capecitabine—breast cancer	3.15e-05	0.000262	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—breast cancer	3.1e-05	0.000258	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—breast cancer	3.09e-05	0.000258	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—breast cancer	3.09e-05	0.000258	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—breast cancer	3.09e-05	0.000258	CcSEcCtD
Lovastatin—Vomiting—Paclitaxel—breast cancer	3.08e-05	0.000257	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—breast cancer	3.08e-05	0.000257	CcSEcCtD
Lovastatin—Malaise—Epirubicin—breast cancer	3.06e-05	0.000256	CcSEcCtD
Lovastatin—Rash—Paclitaxel—breast cancer	3.06e-05	0.000255	CcSEcCtD
Lovastatin—Dermatitis—Paclitaxel—breast cancer	3.06e-05	0.000255	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—breast cancer	3.05e-05	0.000255	CcSEcCtD
Lovastatin—Vertigo—Epirubicin—breast cancer	3.05e-05	0.000255	CcSEcCtD
Lovastatin—Leukopenia—Epirubicin—breast cancer	3.04e-05	0.000254	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—breast cancer	3.04e-05	0.000254	CcSEcCtD
Lovastatin—Headache—Paclitaxel—breast cancer	3.04e-05	0.000253	CcSEcCtD
Lovastatin—Hypersensitivity—Docetaxel—breast cancer	3.03e-05	0.000253	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—breast cancer	3.02e-05	0.000252	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—breast cancer	2.99e-05	0.000249	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—breast cancer	2.96e-05	0.000247	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—breast cancer	2.96e-05	0.000247	CcSEcCtD
Lovastatin—Asthenia—Docetaxel—breast cancer	2.95e-05	0.000246	CcSEcCtD
Lovastatin—Infection—Methotrexate—breast cancer	2.94e-05	0.000245	CcSEcCtD
Lovastatin—Hypersensitivity—Capecitabine—breast cancer	2.93e-05	0.000245	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—breast cancer	2.92e-05	0.000243	CcSEcCtD
Lovastatin—Pruritus—Docetaxel—breast cancer	2.91e-05	0.000243	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—breast cancer	2.9e-05	0.000242	CcSEcCtD
Lovastatin—Chest pain—Epirubicin—breast cancer	2.89e-05	0.000241	CcSEcCtD
Lovastatin—Arthralgia—Epirubicin—breast cancer	2.89e-05	0.000241	CcSEcCtD
Lovastatin—Myalgia—Epirubicin—breast cancer	2.89e-05	0.000241	CcSEcCtD
Lovastatin—Anxiety—Epirubicin—breast cancer	2.88e-05	0.00024	CcSEcCtD
Lovastatin—Nausea—Paclitaxel—breast cancer	2.88e-05	0.00024	CcSEcCtD
Lovastatin—Discomfort—Epirubicin—breast cancer	2.86e-05	0.000238	CcSEcCtD
Lovastatin—Asthenia—Capecitabine—breast cancer	2.86e-05	0.000238	CcSEcCtD
Lovastatin—Malaise—Doxorubicin—breast cancer	2.84e-05	0.000236	CcSEcCtD
Lovastatin—Dry mouth—Epirubicin—breast cancer	2.83e-05	0.000236	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—breast cancer	2.83e-05	0.000236	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—breast cancer	2.83e-05	0.000236	CcSEcCtD
Lovastatin—Pruritus—Capecitabine—breast cancer	2.82e-05	0.000235	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—breast cancer	2.81e-05	0.000235	CcSEcCtD
Lovastatin—Diarrhoea—Docetaxel—breast cancer	2.81e-05	0.000235	CcSEcCtD
Lovastatin—Confusional state—Epirubicin—breast cancer	2.8e-05	0.000233	CcSEcCtD
Lovastatin—Anaphylactic shock—Epirubicin—breast cancer	2.77e-05	0.000231	CcSEcCtD
Lovastatin—Infection—Epirubicin—breast cancer	2.76e-05	0.00023	CcSEcCtD
Lovastatin—Diarrhoea—Capecitabine—breast cancer	2.72e-05	0.000227	CcSEcCtD
Lovastatin—Dizziness—Docetaxel—breast cancer	2.72e-05	0.000227	CcSEcCtD
Lovastatin—Thrombocytopenia—Epirubicin—breast cancer	2.72e-05	0.000226	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methotrexate—breast cancer	2.7e-05	0.000225	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—breast cancer	2.68e-05	0.000223	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—breast cancer	2.68e-05	0.000223	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—breast cancer	2.68e-05	0.000223	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—breast cancer	2.68e-05	0.000223	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—breast cancer	2.67e-05	0.000222	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—breast cancer	2.66e-05	0.000222	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—breast cancer	2.65e-05	0.000221	CcSEcCtD
Lovastatin—Anorexia—Epirubicin—breast cancer	2.64e-05	0.00022	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—breast cancer	2.64e-05	0.00022	CcSEcCtD
Lovastatin—Dizziness—Capecitabine—breast cancer	2.63e-05	0.000219	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—breast cancer	2.62e-05	0.000218	CcSEcCtD
Lovastatin—Vomiting—Docetaxel—breast cancer	2.61e-05	0.000218	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—breast cancer	2.61e-05	0.000218	CcSEcCtD
Lovastatin—Rash—Docetaxel—breast cancer	2.59e-05	0.000216	CcSEcCtD
Lovastatin—Dermatitis—Docetaxel—breast cancer	2.59e-05	0.000216	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—breast cancer	2.59e-05	0.000216	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—breast cancer	2.58e-05	0.000215	CcSEcCtD
Lovastatin—Headache—Docetaxel—breast cancer	2.58e-05	0.000215	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—breast cancer	2.57e-05	0.000214	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—breast cancer	2.56e-05	0.000213	CcSEcCtD
Lovastatin—Infection—Doxorubicin—breast cancer	2.55e-05	0.000213	CcSEcCtD
Lovastatin—Pain—Methotrexate—breast cancer	2.53e-05	0.000211	CcSEcCtD
Lovastatin—Vomiting—Capecitabine—breast cancer	2.53e-05	0.000211	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.53e-05	0.000211	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—breast cancer	2.51e-05	0.000209	CcSEcCtD
Lovastatin—Rash—Capecitabine—breast cancer	2.51e-05	0.000209	CcSEcCtD
Lovastatin—Insomnia—Epirubicin—breast cancer	2.51e-05	0.000209	CcSEcCtD
Lovastatin—Dermatitis—Capecitabine—breast cancer	2.51e-05	0.000209	CcSEcCtD
Lovastatin—Headache—Capecitabine—breast cancer	2.49e-05	0.000208	CcSEcCtD
Lovastatin—Paraesthesia—Epirubicin—breast cancer	2.49e-05	0.000208	CcSEcCtD
Lovastatin—Dyspnoea—Epirubicin—breast cancer	2.47e-05	0.000206	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—breast cancer	2.45e-05	0.000204	CcSEcCtD
Lovastatin—Nausea—Docetaxel—breast cancer	2.44e-05	0.000204	CcSEcCtD
Lovastatin—Feeling abnormal—Methotrexate—breast cancer	2.44e-05	0.000204	CcSEcCtD
Lovastatin—Dyspepsia—Epirubicin—breast cancer	2.44e-05	0.000204	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—breast cancer	2.42e-05	0.000202	CcSEcCtD
Lovastatin—Decreased appetite—Epirubicin—breast cancer	2.41e-05	0.000201	CcSEcCtD
Lovastatin—Fatigue—Epirubicin—breast cancer	2.39e-05	0.000199	CcSEcCtD
Lovastatin—Constipation—Epirubicin—breast cancer	2.37e-05	0.000198	CcSEcCtD
Lovastatin—Pain—Epirubicin—breast cancer	2.37e-05	0.000198	CcSEcCtD
Lovastatin—Nausea—Capecitabine—breast cancer	2.36e-05	0.000197	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—breast cancer	2.35e-05	0.000196	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—breast cancer	2.34e-05	0.000195	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—breast cancer	2.34e-05	0.000195	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.34e-05	0.000195	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—breast cancer	2.32e-05	0.000194	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—breast cancer	2.3e-05	0.000192	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—breast cancer	2.29e-05	0.000191	CcSEcCtD
Lovastatin—Feeling abnormal—Epirubicin—breast cancer	2.29e-05	0.000191	CcSEcCtD
Lovastatin—Gastrointestinal pain—Epirubicin—breast cancer	2.27e-05	0.000189	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—breast cancer	2.26e-05	0.000188	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—breast cancer	2.23e-05	0.000186	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—breast cancer	2.21e-05	0.000184	CcSEcCtD
Lovastatin—Urticaria—Epirubicin—breast cancer	2.2e-05	0.000184	CcSEcCtD
Lovastatin—Pain—Doxorubicin—breast cancer	2.19e-05	0.000183	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—breast cancer	2.19e-05	0.000183	CcSEcCtD
Lovastatin—Abdominal pain—Epirubicin—breast cancer	2.19e-05	0.000183	CcSEcCtD
Lovastatin—Body temperature increased—Epirubicin—breast cancer	2.19e-05	0.000183	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—breast cancer	2.18e-05	0.000182	CcSEcCtD
Lovastatin—Asthenia—Methotrexate—breast cancer	2.13e-05	0.000177	CcSEcCtD
Lovastatin—Feeling abnormal—Doxorubicin—breast cancer	2.11e-05	0.000176	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—breast cancer	2.1e-05	0.000175	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—breast cancer	2.1e-05	0.000175	CcSEcCtD
Lovastatin—Hypersensitivity—Epirubicin—breast cancer	2.04e-05	0.00017	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—breast cancer	2.04e-05	0.00017	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—breast cancer	2.03e-05	0.000169	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—breast cancer	2.03e-05	0.000169	CcSEcCtD
Lovastatin—Diarrhoea—Methotrexate—breast cancer	2.03e-05	0.000169	CcSEcCtD
Lovastatin—Asthenia—Epirubicin—breast cancer	1.99e-05	0.000166	CcSEcCtD
Lovastatin—Pruritus—Epirubicin—breast cancer	1.96e-05	0.000164	CcSEcCtD
Lovastatin—Dizziness—Methotrexate—breast cancer	1.96e-05	0.000163	CcSEcCtD
Lovastatin—Diarrhoea—Epirubicin—breast cancer	1.9e-05	0.000158	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—breast cancer	1.89e-05	0.000158	CcSEcCtD
Lovastatin—Vomiting—Methotrexate—breast cancer	1.88e-05	0.000157	CcSEcCtD
Lovastatin—Rash—Methotrexate—breast cancer	1.87e-05	0.000156	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—breast cancer	1.87e-05	0.000156	CcSEcCtD
Lovastatin—Headache—Methotrexate—breast cancer	1.86e-05	0.000155	CcSEcCtD
Lovastatin—Asthenia—Doxorubicin—breast cancer	1.84e-05	0.000154	CcSEcCtD
Lovastatin—Dizziness—Epirubicin—breast cancer	1.83e-05	0.000153	CcSEcCtD
Lovastatin—Pruritus—Doxorubicin—breast cancer	1.82e-05	0.000151	CcSEcCtD
Lovastatin—Vomiting—Epirubicin—breast cancer	1.76e-05	0.000147	CcSEcCtD
Lovastatin—Nausea—Methotrexate—breast cancer	1.76e-05	0.000147	CcSEcCtD
Lovastatin—Diarrhoea—Doxorubicin—breast cancer	1.76e-05	0.000146	CcSEcCtD
Lovastatin—Rash—Epirubicin—breast cancer	1.75e-05	0.000146	CcSEcCtD
Lovastatin—Dermatitis—Epirubicin—breast cancer	1.75e-05	0.000146	CcSEcCtD
Lovastatin—Headache—Epirubicin—breast cancer	1.74e-05	0.000145	CcSEcCtD
Lovastatin—Dizziness—Doxorubicin—breast cancer	1.7e-05	0.000141	CcSEcCtD
Lovastatin—Nausea—Epirubicin—breast cancer	1.65e-05	0.000137	CcSEcCtD
Lovastatin—Vomiting—Doxorubicin—breast cancer	1.63e-05	0.000136	CcSEcCtD
Lovastatin—Rash—Doxorubicin—breast cancer	1.62e-05	0.000135	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—breast cancer	1.62e-05	0.000135	CcSEcCtD
Lovastatin—Headache—Doxorubicin—breast cancer	1.61e-05	0.000134	CcSEcCtD
Lovastatin—Nausea—Doxorubicin—breast cancer	1.52e-05	0.000127	CcSEcCtD
Lovastatin—CYP3A5—Metabolism—ERCC2—breast cancer	1.56e-06	1.52e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK8—breast cancer	1.56e-06	1.52e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.56e-06	1.52e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CB—breast cancer	1.55e-06	1.51e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HMOX1—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A1—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NQO1—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ITPR1—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HSP90AA1—breast cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NCOA1—breast cancer	1.53e-06	1.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NQO1—breast cancer	1.53e-06	1.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A1—breast cancer	1.53e-06	1.49e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—STK11—breast cancer	1.51e-06	1.47e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP19A1—breast cancer	1.51e-06	1.47e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP3A4—breast cancer	1.5e-06	1.46e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CD—breast cancer	1.5e-06	1.46e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.49e-06	1.46e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NCOA1—breast cancer	1.49e-06	1.46e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP3A4—breast cancer	1.49e-06	1.45e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—breast cancer	1.48e-06	1.45e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.48e-06	1.44e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—breast cancer	1.48e-06	1.44e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—breast cancer	1.48e-06	1.44e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SRC—breast cancer	1.48e-06	1.44e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1B1—breast cancer	1.48e-06	1.44e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—STK11—breast cancer	1.47e-06	1.43e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP19A1—breast cancer	1.47e-06	1.43e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—breast cancer	1.47e-06	1.43e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1B1—breast cancer	1.46e-06	1.43e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TYMS—breast cancer	1.45e-06	1.42e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.45e-06	1.41e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—breast cancer	1.44e-06	1.4e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—breast cancer	1.44e-06	1.4e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.44e-06	1.4e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NCOR1—breast cancer	1.44e-06	1.4e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—breast cancer	1.44e-06	1.4e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.43e-06	1.4e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—breast cancer	1.42e-06	1.39e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.42e-06	1.39e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—breast cancer	1.42e-06	1.38e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.42e-06	1.38e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—breast cancer	1.41e-06	1.38e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—breast cancer	1.41e-06	1.37e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—breast cancer	1.41e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NCOA1—breast cancer	1.41e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—COMT—breast cancer	1.4e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTP1—breast cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NCOA1—breast cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—STK11—breast cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP19A1—breast cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HMOX1—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX1—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP19A1—breast cancer	1.37e-06	1.34e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—STK11—breast cancer	1.37e-06	1.34e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ITPR1—breast cancer	1.37e-06	1.34e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—breast cancer	1.37e-06	1.34e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MED12—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—DPYD—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—COMT—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTP1—breast cancer	1.36e-06	1.33e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP1A1—breast cancer	1.36e-06	1.33e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK3—breast cancer	1.36e-06	1.33e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAV1—breast cancer	1.35e-06	1.32e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ERCC2—breast cancer	1.35e-06	1.32e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALDOA—breast cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HMOX1—breast cancer	1.34e-06	1.31e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—breast cancer	1.34e-06	1.31e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ITPR1—breast cancer	1.34e-06	1.31e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—breast cancer	1.32e-06	1.29e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—breast cancer	1.32e-06	1.29e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—breast cancer	1.32e-06	1.29e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—breast cancer	1.31e-06	1.28e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOA3—breast cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CB—breast cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A2—breast cancer	1.3e-06	1.27e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TYMS—breast cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—COMT—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTP1—breast cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NCOR1—breast cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—breast cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—COMT—breast cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTR—breast cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CPT1A—breast cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCG2—breast cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTP1—breast cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—breast cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TYMS—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMOX1—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ITPR1—breast cancer	1.26e-06	1.23e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMOX1—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ITPR1—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NCOR1—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PLA2G4A—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HPGDS—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HBA1—breast cancer	1.24e-06	1.21e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CG—breast cancer	1.23e-06	1.2e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—breast cancer	1.23e-06	1.2e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX1—breast cancer	1.23e-06	1.2e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—breast cancer	1.22e-06	1.19e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP1A1—breast cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—breast cancer	1.21e-06	1.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTT1—breast cancer	1.21e-06	1.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ACHE—breast cancer	1.21e-06	1.18e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ERCC2—breast cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX1—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TYMS—breast cancer	1.19e-06	1.16e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP1A1—breast cancer	1.19e-06	1.16e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TYMS—breast cancer	1.18e-06	1.15e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NCOR1—breast cancer	1.18e-06	1.15e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.18e-06	1.15e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—breast cancer	1.18e-06	1.15e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ERCC2—breast cancer	1.18e-06	1.15e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAV1—breast cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NCOR1—breast cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—breast cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—breast cancer	1.16e-06	1.13e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP17A1—breast cancer	1.15e-06	1.12e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ENO1—breast cancer	1.13e-06	1.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS1—breast cancer	1.13e-06	1.11e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—breast cancer	1.13e-06	1.1e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX1—breast cancer	1.13e-06	1.1e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—breast cancer	1.13e-06	1.1e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX1—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1A1—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2D6—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ERCC2—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1A1—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ERCC2—breast cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOA2—breast cancer	1.09e-06	1.06e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—breast cancer	1.09e-06	1.06e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CD—breast cancer	1.08e-06	1.05e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—breast cancer	1.07e-06	1.04e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CG—breast cancer	1.07e-06	1.04e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FASN—breast cancer	1.06e-06	1.03e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BCHE—breast cancer	1.05e-06	1.03e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAV1—breast cancer	1.05e-06	1.02e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—breast cancer	1.04e-06	1.02e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC5A5—breast cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—breast cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—breast cancer	1.03e-06	1.01e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—breast cancer	1.02e-06	9.96e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAV1—breast cancer	1.02e-06	9.94e-06	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—breast cancer	1.01e-06	9.88e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A1—breast cancer	1.01e-06	9.8e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NQO1—breast cancer	1.01e-06	9.8e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.99e-07	9.73e-06	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—breast cancer	9.94e-07	9.69e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1B1—breast cancer	9.64e-07	9.4e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAV1—breast cancer	9.61e-07	9.37e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAV1—breast cancer	9.53e-07	9.29e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CG—breast cancer	9.52e-07	9.28e-06	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—breast cancer	9.51e-07	9.27e-06	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—breast cancer	9.46e-07	9.22e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HSP90AA1—breast cancer	9.46e-07	9.22e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CB—breast cancer	9.44e-07	9.19e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CD—breast cancer	9.38e-07	9.14e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—breast cancer	9.35e-07	9.11e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CG—breast cancer	9.29e-07	9.06e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—breast cancer	9.26e-07	9.02e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOA1—breast cancer	9.2e-07	8.97e-06	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—breast cancer	9.17e-07	8.94e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.1e-07	8.87e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—STK11—breast cancer	9.07e-07	8.84e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP19A1—breast cancer	9.07e-07	8.84e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—breast cancer	8.85e-07	8.63e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CG—breast cancer	8.76e-07	8.53e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CG—breast cancer	8.68e-07	8.46e-06	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—breast cancer	8.67e-07	8.45e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—COMT—breast cancer	8.43e-07	8.21e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTP1—breast cancer	8.39e-07	8.18e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CD—breast cancer	8.37e-07	8.16e-06	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—breast cancer	8.28e-07	8.07e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMOX1—breast cancer	8.27e-07	8.06e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—breast cancer	8.26e-07	8.05e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ITPR1—breast cancer	8.26e-07	8.04e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CB—breast cancer	8.17e-07	7.96e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CD—breast cancer	8.17e-07	7.96e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—breast cancer	8.15e-07	7.95e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—breast cancer	8.1e-07	7.89e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—breast cancer	8.06e-07	7.86e-06	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—breast cancer	7.96e-07	7.75e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—breast cancer	7.94e-07	7.74e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—breast cancer	7.9e-07	7.7e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMS—breast cancer	7.8e-07	7.6e-06	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—breast cancer	7.73e-07	7.53e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—breast cancer	7.71e-07	7.52e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLA2G4A—breast cancer	7.71e-07	7.51e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—breast cancer	7.71e-07	7.51e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOR1—breast cancer	7.71e-07	7.51e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CD—breast cancer	7.7e-07	7.5e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CD—breast cancer	7.63e-07	7.44e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—breast cancer	7.6e-07	7.41e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—breast cancer	7.53e-07	7.34e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX1—breast cancer	7.38e-07	7.19e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1A1—breast cancer	7.31e-07	7.12e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CB—breast cancer	7.29e-07	7.11e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—breast cancer	7.27e-07	7.08e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ERCC2—breast cancer	7.25e-07	7.06e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—breast cancer	7.23e-07	7.04e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—breast cancer	7.21e-07	7.02e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CB—breast cancer	7.12e-07	6.94e-06	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—breast cancer	7.08e-07	6.9e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—breast cancer	7.06e-07	6.88e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—breast cancer	7.05e-07	6.87e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—breast cancer	6.81e-07	6.64e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CB—breast cancer	6.71e-07	6.54e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CB—breast cancer	6.65e-07	6.48e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—breast cancer	6.65e-07	6.48e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—breast cancer	6.59e-07	6.42e-06	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—breast cancer	6.5e-07	6.33e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—breast cancer	6.3e-07	6.14e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAV1—breast cancer	6.28e-07	6.12e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—breast cancer	6.15e-07	6e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—breast cancer	5.8e-07	5.65e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—breast cancer	5.75e-07	5.61e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—breast cancer	5.75e-07	5.6e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CG—breast cancer	5.72e-07	5.58e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CD—breast cancer	5.03e-07	4.9e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—breast cancer	4.98e-07	4.86e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—breast cancer	4.97e-07	4.84e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—breast cancer	4.75e-07	4.63e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—breast cancer	4.7e-07	4.58e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—breast cancer	4.45e-07	4.33e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CB—breast cancer	4.39e-07	4.27e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—breast cancer	4.35e-07	4.24e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—breast cancer	4.34e-07	4.23e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—breast cancer	4.09e-07	3.99e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—breast cancer	4.07e-07	3.97e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—breast cancer	4.05e-07	3.95e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—breast cancer	3.79e-07	3.69e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—breast cancer	3.63e-07	3.54e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—breast cancer	3.55e-07	3.46e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—breast cancer	3.34e-07	3.26e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—breast cancer	3.31e-07	3.23e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—breast cancer	2.67e-07	2.61e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—breast cancer	2.18e-07	2.13e-06	CbGpPWpGaD
